Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis

PLoS One. 2011;6(7):e22532. doi: 10.1371/journal.pone.0022532. Epub 2011 Jul 19.

Abstract

Amyloidoses constitute a group of diseases in which soluble proteins aggregate and deposit extracellularly in tissues. Nonhereditary apolipoprotein A-I (apoA-I) amyloid is characterized by deposits of nonvariant protein in atherosclerotic arteries. Despite being common, little is known about the pathogenesis and significance of apoA-I deposition. In this work we investigated by fluorescence and biochemical approaches the impact of a cellular microenvironment associated with chronic inflammation on the folding and pro-amyloidogenic processing of apoA-I. Results showed that mildly acidic pH promotes misfolding, aggregation, and increased binding of apoA-I to extracellular matrix elements, thus favoring protein deposition as amyloid like-complexes. In addition, activated neutrophils and oxidative/proteolytic cleavage of the protein give rise to pro amyloidogenic products. We conclude that, even though apoA-I is not inherently amyloidogenic, it may produce non hereditary amyloidosis as a consequence of the pro-inflammatory microenvironment associated to atherogenesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / metabolism*
  • Anilino Naphthalenesulfonates / metabolism
  • Animals
  • Apolipoprotein A-I / chemistry
  • Apolipoprotein A-I / metabolism*
  • Apolipoprotein A-I / ultrastructure
  • Atherosclerosis / metabolism*
  • Benzothiazoles
  • CHO Cells
  • Cholesterol / metabolism
  • Cricetinae
  • Cricetulus
  • Heparin / metabolism
  • Humans
  • Hydrogen-Ion Concentration / drug effects
  • Hypochlorous Acid / pharmacology
  • Matrix Metalloproteinase 12 / metabolism
  • Neutrophil Activation / drug effects
  • Oxidation-Reduction / drug effects
  • Protein Binding / drug effects
  • Protein Folding / drug effects
  • Protein Stability / drug effects
  • Protein Structure, Quaternary
  • Protein Structure, Secondary
  • Proteolysis / drug effects
  • Solvents
  • Tetradecanoylphorbol Acetate / pharmacology
  • Thiazoles / metabolism
  • Tryptophan / metabolism

Substances

  • APOA1 protein, human
  • Amyloid
  • Anilino Naphthalenesulfonates
  • Apolipoprotein A-I
  • Benzothiazoles
  • Solvents
  • Thiazoles
  • thioflavin T
  • 5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)
  • Hypochlorous Acid
  • Tryptophan
  • Heparin
  • Cholesterol
  • Matrix Metalloproteinase 12
  • Tetradecanoylphorbol Acetate